← FDA DRUG APPROVALS

FDA NDA · NDA020385

NICOTROL

nicotine

Sponsor: PFIZER INC

APPLICATION
NDA020385
TYPE
NDA
ORIGINAL APPROVAL
1996-03-22
LATEST ACTION
2024-05-23
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Prescription

Products

NICOTROL · ReferencePrescription
NICOTINE 0.5MG/SPRAY · SPRAY, METERED · NASAL

Approval history

2024-05-23Labeling · Supplement 12 · standardLetterAP
2019-08-29Labeling · Supplement 11 · standardLabelAP
2010-06-29Labeling · Supplement 10 · unknownLetterAP
2004-07-16Labeling · Supplement 7 · standardLetterAP
2003-11-06Labeling · Supplement 6 · standardLetterAP
2002-09-08Labeling · Supplement 5 · standardLetterAP
2001-07-09Labeling · Supplement 3 · standardAP
1998-08-14Manufacturing (CMC) · Supplement 1 · standardAP
1996-03-22Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →